The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Open accessAbstract
The development of traditional tumor-targeted drug delivery systems based on EPR effect and receptor-mediated endocytosis is very challenging probably because of the biological complexity of tumors as well as the limitations in the design of the functional nano-sized delivery systems. Recently, multistage drug delivery systems (Ms-DDS) triggered by various specific tumor microenvironment stimuli have emerged for tumor therapy and imaging. In response to the differences in the physiological blood circulation, tumor microenvironment, and intracellular environment, Ms-DDS can change their physicochemical properties (such as size, hydrophobicity, or zeta potential) to achieve deeper tumor penetration, enhanced cellular uptake, timely drug release, as well as effective endosomal escape. Based on these mechanisms, Ms-DDS could deliver maximum quantity of drugs to the therapeutic targets including tumor tissues, cells, and subcellular organelles and eventually exhibit the highest therapeutic efficacy. In this review, we expatiate on various responsive modes triggered by the tumor microenvironment stimuli, introduce recent advances in multistage nanoparticle systems, especially the multi-stimuli responsive delivery systems, and discuss their functions, effects, and prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Synthesis and In vitro efficacy of acid-Sensitive poly(ethylene glycol) paclitaxel conjugates
Rodrigues, P. C. A., Scheuermann, K., Stockmar, C., Maier, G., Fiebig, H., Unger, C., Mülhaupt, R., & Kratz, F. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01002-8 · Cited by 52
pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis
Choi, J.-W., Jung, S.-J., Kasala, D., Hwang, J. K., Hu, J., Bae, Y. H., & Yun, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.005 · Cited by 51
Zhang, H., Wang, L., Xiang, Q., Zhong, Q., Chen, L., Xu, C., Xiang, X., Xu, B., Meng, F., Wan, Y., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.046 · Cited by 50
Self-citationLi, S., Wu, W., Xiu, K., Xu, F., Li, Z., & Li, J. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1846 · Cited by 48
Karve, S., Bandekar, A., Ali, M. R., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.064 · Cited by 47
Sequential Intra‐Intercellular Nanoparticle Delivery System for Deep Tumor Penetration
Ju, C., Mo, R., Xue, J., Zhang, L., Zhao, Z., Xue, L., Ping, Q., & Zhang, C. (2014) · Angewandte Chemie · doi:10.1002/ange.201311227 · Cited by 46
Hatakeyama, H., Akita, H., Kogure, K., & Harashima, H. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.1549 · Cited by 43
Disulfide-Bridged Cleavable PEGylation in Polymeric Nanomedicine for Controlled Therapeutic Delivery
Dong, H., Tang, M., Li, Y., Li, Y., Qian, D., & Shi, D. (2015) · Nanomedicine · doi:10.2217/nnm.15.38 · Cited by 42
Yuan, Y., Ding, D., Li, K., Liu, J., & Liu, B. (2014) · Small · doi:10.1002/smll.201302765 · Cited by 42
Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin
Bandekar, A., Karve, S., Chang, M.-Y., Mu, Q., Rotolo, J. A., & Sofou, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.039 · Cited by 42
Wu, L., Zhang, L., Shi, G., & Ni, C. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.12.025 · Cited by 40
Liu, Y., Gao, F., Zhang, D., Fan, Y., Chen, X., & Wang, H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.033 · Cited by 35
Ueki, N., Wang, W., Swenson, C., McNaughton, C., Sampson, N. S., & Hayman, M. J. (2016) · Theranostics · doi:10.7150/thno.13826 · Cited by 35
Lu, T., Chen, T., Wang, Ma, Y., & Zhang (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35576 · Cited by 33
Arouri, A., Dathe, M., & Blume, A. (2013) · Biophysical Chemistry · doi:10.1016/j.bpc.2013.05.003 · Cited by 32
Mizuhara, T., Saha, K., Moyano, D. F., Kim, C. S., Yan, B., Kim, Y., & Rotello, V. M. (2015) · Angewandte Chemie · doi:10.1002/ange.201411615 · Cited by 28
A Phenylboronate‐Functionalized Polyion Complex Micelle for ATP‐Triggered Release of siRNA
Naito, M., Ishii, T., Matsumoto, A., Miyata, K., Miyahara, Y., & Kataoka, K. (2012) · Angewandte Chemie · doi:10.1002/ange.201203360 · Cited by 27
Xu, X., Wu, J., Liu, Y., Yu, M., Zhao, L., Zhu, X., Bhasin, S., Li, Q., Ha, E., Shi, J., et al. (2016) · Angewandte Chemie · doi:10.1002/ange.201601273 · Cited by 15
Li, Y., & Zhang, X. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.211 · Cited by 3
Cited by
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
Liu, R., Luo, C., Pang, Z., Zhang, J., Ruan, S., Wu, M., Wang, L., Sun, T., Li, N., Han, L., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.05.032 · Cited by 516
Advances in redox-responsive drug delivery systems of tumor microenvironment
Guo, X., Cheng, Y., Zhao, X., Luo, Y., Chen, J., & Yuan, W.-E. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0398-2 · Cited by 459
Development of endogenous enzyme-responsive nanomaterials for theranostics
Mu, J., Lin, J., Huang, P., & Chen, X. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00663b · Cited by 393
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
Zhou, Z., Liu, X., Zhu, D., Wang, Y., Zhang, Z., Zhou, X., Qiu, N., Chen, X., & Shen, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.021 · Cited by 379
Self-citation
Metadata
- Authors
- Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 7
- Issue
- 3
- Pages
- 538-558
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2575553491
- Cited by
- 342
- References
- 219
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.